Recipharm is currently owned by EQT, through EQT IX, since 2021.

When did EQT acquire Recipharm?

EQT acquired Recipharm in 2021 (active for 5 years).

Home/Companies/Pharma/Recipharm

Recipharm

Pharma·

Sweden·Active·5yr hold

Entry

2021

Hold

5yr

Status

Active

Who owns Recipharm?

Recipharm is currently owned by EQT through EQT IX (2021 vintage), since 2021. Across its history, Recipharm has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Most recent investor

EQT

EQT IX · 2021 · Buyout

3 ownership periods · full history below

Key facts

HQSweden

SectorPharma

Websitewww.recipharm.com

Ownership history

2 ownership periods · co-invest detected · 1 lender on file

Active

Co-held by Ardian and EQT since 2021.

Co-invest · 2 holders · 1 lender · 2021 · present

CIC Private DebtLender

2021 · present(5yr) · CM-CIC Debt Fund 3 · 2019 · Private Debt

EQTActive

2021 · present(5yr) · EQT IX · 2021 · Buyout

ArdianActive

2021 · present(5yr) · Ardian Co-Investment Fund V · 2019 · Buyout

More from EQT IX

Other portfolio companies in the same fund.

More PE-backed in Pharma

Comparable pharma deals from other GPs.

General AtlanticChina

Ideal Cures Pvt. Ltd.

Active

TA AssociatesIndia

Track Recipharm

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Recipharm.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment

Save this company to your watchlist

Exit buyers and MOIC on realized deals (Pro)

Continue with email

Already a member? Sign in

Look up another firm or company

Data refreshed weekly · Sourced from public filings · Report an issue